𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice

✍ Scribed by Makovec, F.; Bani, M.; Cereda, R.; Chistè, R.; Revel, L.; Rovati, L.C.; Setnikar, I.; Rovati, L.A.

Book ID
122777777
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
512 KB
Volume
7
Category
Article
ISSN
0196-9781

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of cholecystokinin analogue caeru
Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat
✍ Cosimo Sperti; Carmelo Militello; Roubik Behboo; Edwin Khajeturian; Sergio Pedra 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

The effects of the cholecystokinin (CCK)-analogue, caerulein, and CCKreceptor antagonist lorglumide (CR-1409) on pancreatic carcinogenesis induced by 7,12-dimethylbenz(a)anthracene (DMBA) were studied. One hundred thirty rats were divided into the following 10 treatment groups: group 1, DMBA (2-3 mg

Inhibitory effects of a cholecystokinin
Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer
✍ Hideki Morimoto; Dr. Yoshinori Nio; Michihiko Tsubono; Chen-Chiu Tseng; Kazuya K 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR-1505), on four freshly separated and six xenografted human pancreatic cancers, were investigated. The level of DNA synthesis in only one of five tested pancreatic cancers was enhanced by CCK at concentrations of 0.01-10 nM, w